A new research review has found that a diabetes drug called Tirzepatide may work better than another well-known drug, Semaglutide, for lowering blood sugar and helping people lose weight.
The findings were presented at the Annual Meeting of the European Association for the Study of Diabetes, one of the world’s largest conferences focused on diabetes research and treatment.
The study was led by Dr. Thomas Karagiannis and his research team from Aristotle University in Greece. The researchers examined data from 22 high-quality clinical trials involving almost 18,500 people with Type 2 diabetes.
By combining results from many studies, the team hoped to better understand which medication gives patients the greatest benefits and what side effects may come with treatment.
Type 2 diabetes is one of the most common long-term health conditions in the world. It happens when the body becomes resistant to insulin or cannot produce enough insulin to control blood sugar properly.
Insulin is a hormone that helps move sugar from the blood into cells to be used for energy. When this system stops working well, blood sugar levels stay too high.
Over time, high blood sugar can seriously damage the body. It can increase the risk of heart disease, stroke, kidney disease, nerve damage, vision problems, and other major health issues.
Millions of people worldwide live with Type 2 diabetes, and the numbers continue to rise, partly because of increasing obesity rates and less active lifestyles.
Managing weight is an important part of diabetes treatment because excess body fat can make insulin resistance worse. This is one reason why newer diabetes medications that also help people lose weight have gained so much attention in recent years.
Both Tirzepatide and Semaglutide belong to a newer group of medicines that help control appetite and blood sugar. Semaglutide is already widely known around the world because it is used in drugs such as Ozempic and Wegovy.
Tirzepatide is sold under brand names such as Mounjaro. These medicines work by copying natural hormones in the body that help people feel full after eating, slow down digestion, and improve blood sugar control.
Semaglutide works by copying a hormone called GLP-1. Tirzepatide is slightly different because it targets both GLP-1 and another hormone called GIP. Scientists believe this double action may explain why Tirzepatide appears to have stronger effects on both blood sugar and body weight.
In the new analysis, the researchers found that Tirzepatide lowered blood sugar levels more effectively than Semaglutide. They measured blood sugar using a test called HbA1c. This blood test shows average blood sugar levels over the previous two to three months and is commonly used by doctors to monitor diabetes control.
People taking the highest dose of Tirzepatide, which was 15 milligrams, had an average HbA1c reduction of 2.00%. In comparison, people taking 2.0 milligrams of Semaglutide had a smaller average reduction of 1.62%. Although both medicines improved blood sugar control, Tirzepatide showed stronger results.
The study also found major differences in weight loss. Participants taking 15 milligrams of Tirzepatide lost around 5.7 kilograms more than those taking Semaglutide.
This finding is important because weight loss can improve many aspects of health for people with Type 2 diabetes. Losing weight may help lower blood pressure, improve cholesterol levels, reduce stress on joints, and improve the body’s response to insulin.
The strong weight loss effects of these medicines have also attracted attention outside diabetes care. Many doctors are now studying whether these drugs may help treat obesity even in people who do not have diabetes.
Obesity itself is linked to many serious conditions, including heart disease, sleep apnea, fatty liver disease, and some cancers.
However, the researchers also looked carefully at side effects. Both drugs commonly caused stomach-related problems such as nausea, vomiting, diarrhea, and stomach discomfort. These side effects are already known to happen with medications in this drug family.
The highest dose of Tirzepatide appeared to cause these stomach problems more often than Semaglutide or lower doses of Tirzepatide. Some patients were more likely to feel sick or stop treatment because of the side effects.
This means that while the stronger dose may offer greater benefits, it may also be harder for some people to tolerate.
The researchers explained that doctors and patients should consider both the benefits and risks when choosing treatment.
For some people, the larger improvements in blood sugar and weight may outweigh the side effects. For others, especially people sensitive to stomach problems, a different option or lower dose may be more suitable.
The study findings may help shape future diabetes treatment decisions around the world. As more people develop Type 2 diabetes and obesity, doctors are looking for treatments that can improve several health problems at the same time.
Researchers also expect to share more detailed information from the study during a live scientific presentation at the conference. This may include additional results about weight loss, safety, and how different groups of patients responded to the medications.
The findings suggest that Tirzepatide may become one of the most powerful medicines currently available for treating Type 2 diabetes and obesity. Still, experts say more long-term research is needed to better understand the safety and effectiveness of the drug over many years.
Patients are also reminded not to change medications without speaking to a doctor first. Diabetes treatment should always be based on a person’s full health picture, including blood sugar levels, weight, heart health, medical history, and possible side effects.
This research shows how quickly diabetes treatment is changing. New medicines are not only helping people control blood sugar more effectively but are also offering new ways to manage obesity and improve overall health.
If you care about diabetes, please read studies about bananas and diabetes, and honey could help control blood sugar.
For more health information, please see recent studies about Vitamin D that may reduce dangerous complications in diabetes and plant-based protein foods may help reverse type 2 diabetes.
Copyright © 2026 Knowridge Science Report. All rights reserved.
